期刊文献+

肺癌化疗中吉非替尼和吉西他滨不良反应的药学服务 被引量:3

Pharmaceutical care in adverse reactions of gefitinib and gemcitabine in treating lung cancer
原文传递
导出
摘要 目的:临床药师通过参与肿瘤化疗患者的药物治疗(吉非替尼和吉西他滨)实践,为临床提供药学服务。方法:临床药师根据患者病情,与临床医师讨论并查阅相关文献。结果:根据患者的病例进行总结,为临床提供药学信息。结论:临床药师参与临床治疗实践,有利于临床药师积累临床和药学经验,为临床药师学习新药知识和药学监护奠定基础。 Objective: To provide pharmacy services for clinical through the practice of clinical pharmacists by participating in cancer chemotherapy with gefitinib(Iressa) and gemcitabine.Methods: Clinical pharmacists discussed the patient conditions with clinicians,and reviewed the literature.Results: According to summarization of clinical cases,clinical pharmacists provided their effective provision of pharmaceutical information for the medication.Conclusion: The clinical pharmacists participating in clinical practice are conducive to the accumulation of clinical pharmacy and clinical experience for pharmaceutical care.
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第17期1624-1626,共3页 Chinese Journal of New Drugs
关键词 吉非替尼 吉西他滨 不良反应 药学服务 gefitinib gemcitabine adverse reaction pharmaceutical care
  • 相关文献

参考文献7

  • 1JEMAL A, MURRAY T, SAMUELS A, et al. Cancer statistics [ J ]. CA Cancer J Clin ,2003,53 ( 1 ) :5 - 26.
  • 2周留勇,单珍珠,尤建良.易瑞沙致肝损害1例报告[J].中国新药杂志,2007,16(1):86-87. 被引量:6
  • 3JING LI, MING ZHAO, PING HE, et al. Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes[J]. Clinical Cancer Research ,2007,3731 - 3737.
  • 4许亚萍,马胜林,魏启春.Iressa治疗非小细胞肺癌的进展[J].国际肿瘤学杂志,2006,33(9):681-684. 被引量:1
  • 5SAIF MW, SHAHROKNI A, CORNFELD D. Gemcitabine-induced liver fibrosis in a patient with pancreatic cancer[ J]. JOP,2007,8 (4) :460 -467.
  • 6MERCIER C, RAYNAL C, DAHAN L, et al. Toxic death case in a patient undergoing gemeitabine-based ebemolherapy in relation with cytidine deaminase downregulation [ J ]. Pharmacogenet Genomics, 2007,17 ( 10 ) : 841 - 844.
  • 7CARNEIRO BA, BRAND RE,FINE E, et aL Phase I trial of fixed close rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma [ J ]. Cancer Invest, 2007,25 ( 5 ) :366 - 371.

二级参考文献23

  • 1王彬,张湘茹,储大同.易瑞沙在晚期非小细胞肺癌化疗失败后的作用[J].中华肿瘤杂志,2004,26(12):742-745. 被引量:53
  • 2Kris MG. How todayg developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care. Oncologist,2005,10 Suppl 2:23-29.
  • 3Giaccone G, Herbst RS, Manegold C, et al. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer:a phase Ⅲ trial-INTACT 1. J Clin Oncol, 2004,22(5) :777-784.
  • 4Herbst RS, Giaccone G, Schiller JH, et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase Ⅲ trial- INTACT. J Clin Oncol,2004,22 ( 5 ) :785-794.
  • 5Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase Ⅱ trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial). J Clin Oncol,2003,21(12):2237-2246.
  • 6Kris MG, Natale RB, Herbst RS, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA,2003,290(16) :2149-2158.
  • 7Cufer T, Vrdoljak E, Gaafar R, et al. Phase Ⅱ, open- label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage Ⅲb or Ⅳ) non-small- cell lung cancer. Anticancer Drugs, 2006,17 (4) :401-409.
  • 8Twombly R. Failing survival advantage in crucial trial, future of Iressa is in jeopardy. J Natl Cancer Inst ,2005,97(4) :249-250.
  • 9Albanell J, Rojo F, Averbuch S, et al. Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients:histopathologic and molecular consequences of receptor inhibition. J Clin Oncol,2002,20( 1 ) :110-124.
  • 10Mohamed MK, Ramalingam S, Lin Y, et al. Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer. Ann Oncol, 2005,16 (5) : 780-785.

共引文献5

同被引文献37

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部